Roche Holding AG (OTCMKTS:RHHVF – Get Free Report) shares dropped 0.6% during mid-day trading on Thursday . The company traded as low as $444.90 and last traded at $462.6080. 705 shares traded hands during mid-day trading, a decline of 95% from the average session volume of 13,324 shares. The stock had previously closed at $465.4240.
Roche Trading Down 0.6%
The stock has a 50-day moving average price of $430.14 and a 200 day moving average price of $423.13.
Roche Company Profile
Roche Holding AG, traded on the OTCMKTS under the symbol RHHVF, is a leading global healthcare company with two core business divisions: Pharmaceuticals and Diagnostics. The company focuses on developing innovative medicines and diagnostic tests that address serious diseases, driving advances in personalized healthcare and precision medicine.
In its Pharmaceuticals division, Roche pioneers targeted therapies across oncology, immunology, ophthalmology and neuroscience. Flagship products include monoclonal antibodies and small-molecule treatments such as Herceptin, Avastin and Actemra, which have become standards of care for cancer and autoimmune conditions.
Featured Stories
- Five stocks we like better than Roche
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.
